Literature DB >> 18854444

Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.

C Horbinski1, W S Bartynski, E Carson-Walter, R L Hamilton, H P Tan, S Cheng.   

Abstract

Reversible encephalopathy after transplantation is well recognized. The condition is commonly thought to be related to immune suppression, and a characteristic brain imaging pattern is typically recognized with vasogenic edema in the parietal and occipital regions, typically termed posterior reversible encephalopathy syndrome (PRES). We report the case of a patient with reversible encephalopathy after cardiac transplantation with brain biopsy evidence of endothelial activation, selective intravascular/perivascular T-cell trafficking, and VEGF expression in astrocytes, neurons, and the endothelium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854444      PMCID: PMC4526311          DOI: 10.3174/ajnr.A1311

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

1.  Tacrolimus leukoencephalopathy: a neuropathologic confirmation.

Authors:  Catherine M Lavigne; David A Shrier; Manoj Ketkar; James M Powers
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

2.  Neuropathological correlates of reversible posterior leukoencephalopathy.

Authors:  David Schiff; Maria-Beatriz Lopes
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

4.  FK506-induced fulminant leukoencephalopathy after single-lung transplantation.

Authors:  G K Thyagarajan; A Cobanoglu; W Johnston
Journal:  Ann Thorac Surg       Date:  1997-11       Impact factor: 4.330

5.  Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506)

Authors:  S L Small; M B Fukui; G T Bramblett; B H Eidelman
Journal:  Ann Neurol       Date:  1996-10       Impact factor: 10.422

6.  Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.

Authors:  W S Bartynski; Z Zeigler; M P Spearman; L Lin; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

7.  Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases.

Authors:  G Lanzino; H Cloft; M K Hemstreet; K West; S Alston; M Ishitani
Journal:  Clin Neurol Neurosurg       Date:  1997-08       Impact factor: 1.876

8.  Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping.

Authors:  K J Ahn; W J You; S L Jeong; J W Lee; B S Kim; J H Lee; D W Yang; Y M Son; S T Hahn
Journal:  Neuroradiology       Date:  2004-11-05       Impact factor: 2.804

9.  Widening spectrum of a reversible splenial lesion with transiently reduced diffusion.

Authors:  J Takanashi; A J Barkovich; T Shiihara; H Tada; M Kawatani; H Tsukahara; M Kikuchi; M Maeda
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

10.  Severe tacrolimus leukoencephalopathy after liver transplantation.

Authors:  Janneke Schuuring; Pieter Wesseling; Aad Verrips
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

View more
  18 in total

1.  Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case report.

Authors:  Hilde M H Braakman; Jan Lodder; Alida A Postma; Lambert F R Span; Werner H Mess
Journal:  BMC Neurol       Date:  2010-05-11       Impact factor: 2.474

2.  The posterior reversible encephalopathy syndrome in HIV infection.

Authors:  Sam Nightingale; Chris Wood; Jonathan Ainsworth
Journal:  BMJ Case Rep       Date:  2012-06-25

3.  Reversible cerebral vasoconstriction syndrome: treatment with combined intra-arterial verapamil infusion and intracranial angioplasty.

Authors:  H Farid; J K Tatum; C Wong; V V Halbach; S W Hetts
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

4.  Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28 patients.

Authors:  A Pirker; L Kramer; B Voller; B Loader; E Auff; D Prayer
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-20       Impact factor: 3.825

5.  One and the same.

Authors:  Ryan T Fitzgerald
Journal:  Rev Obstet Gynecol       Date:  2013

6.  Posterior reversible encephalopathy syndrome due to immunosuppressant after living-donor lobar lung transplantation: report of a case.

Authors:  Tsuyoshi Shoji; Toru Bando; Takuji Fujinaga; Fengshi Chen; Mitsutomo Kohno; Miharu Yabe; Hiromasa Yabe; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-04-28

7.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

8.  Chemotherapy-related posterior reversible leukoencephalopathy syndrome.

Authors:  Archit Bhatt; Muhammad U Farooq; Arshad Majid; Mounzer Kassab
Journal:  Nat Clin Pract Neurol       Date:  2009-03

9.  Posterior reversible encephalopathy syndrome associated with hemorrhage.

Authors:  Rosalyn M Aranas; Shyam Prabhakaran; Vivien H Lee
Journal:  Neurocrit Care       Date:  2009-02-19       Impact factor: 3.210

10.  Neurological complications of solid organ transplantation.

Authors:  Amy A Pruitt; Francesc Graus; Myrna R Rosenfeld
Journal:  Neurohospitalist       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.